GlassScriptPhysician profile
John Alvan Stewart
NPI 1265423313
$4,109.66
in general payments reported to CMS, 2019-2025
18 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $151 · 2021: $96.35 · 2022: $267 · 2023: $771 · 2024: $1,288 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,146 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,146.49 |
| Education | $207.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $947.77 | 2021-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $859.67 | 2019-2025 | Tremfya, Simponi, Simponi Aria |
| Ucb, INC. | $640.11 | 2019-2025 | Bimzelx, Cimzia |
| Amgen INC. | $401.14 | 2019-2025 | Otezla, Otezla |
| Novartis Pharmaceuticals Corporation | $363.67 | 2019-2025 | |
| Pfizer INC. | $226.15 | 2022-2025 | |
| Genzyme Corporation | $223.31 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $106.92 | 2022-2025 | Sotyktu |
| Sanofi-Aventis U.S. LLC | $99.99 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $66.90 | 2021-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $39.50 | 2019 | |
| Lilly USA, LLC | $35.27 | 2019-2023 | Taltz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.25 | 2025 | Spevigo |
| Galderma Laboratories, L.P. | $18.02 | 2025 | Nemluvio |
| Arcutis Biotherapeutics, INC. | $16.85 | 2025 | Zoryve |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Revance Therapeutics, INC. | $15.84 | 2024 | Daxxify |
| Coopersurgical, INC. | $14.97 | 2020 | |
| Boston Scientific Corporation | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stewart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.